Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

271
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
271
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.

Journal of clinical medicine·2026
Same author

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same author

Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.

ERJ open research·2026
Same author

Correcting motion-related B<sub>0</sub> inhomogeneities in magnetic resonance imaging via combined spherical harmonics and AC/DC matrix coils using DL-based prediction-simulation study.

Scientific reports·2026
Same author

Perfusion Patterns of Pleura-Based Pulmonary Sarcoma Metastases on Contrast-Enhanced Ultrasound (CEUS): A Single-Center Retrospective Pilot Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Non-contiguous computed tomography lung scans can be manipulated to permit artificial intelligence analyses for interstitial lung disease in systemic sclerosis.

Biology methods & protocols·2026

Related Experiment Video

Updated: Aug 29, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Unsupervised machine learning identifies predictive progression markers of IPF.

Jeanny Pan1, Johannes Hofmanninger1, Karl-Heinz Nenning1

  • 1Computational Imaging Research Lab, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.

European Radiology
|September 6, 2022
PubMed
Summary
This summary is machine-generated.

Unsupervised learning identified lung imaging markers that predict disease progression and outcomes in idiopathic pulmonary fibrosis (IPF). These markers reveal pathways of lung tissue change, offering new insights into IPF progression.

Keywords:
Idiopathic pulmonary fibrosisTomography, X-ray computedUnsupervised machine learning

More Related Videos

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:39

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

274
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

11.6K

Related Experiment Videos

Last Updated: Aug 29, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:39

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

274
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

11.6K

Area of Science:

  • Radiology and Medical Imaging
  • Computational Pathology
  • Pulmonary Medicine

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with variable outcomes.
  • Identifying reliable markers for disease progression and outcome prediction is crucial for patient management.

Purpose of the Study:

  • To identify and evaluate predictive lung imaging markers and their pathways of change during IPF progression using sequential CT data.
  • To test the ability of these imaging markers to predict patient outcomes.

Main Methods:

  • Utilized computed tomography (CT) scans from 76 IPF patients (190 examinations).
  • Employed an algorithm for computational clustering of visual CT features to identify progression markers.
  • Applied classification algorithms to select markers associated with radiological progression and tested their predictive value for outcomes.
  • Performed external validation on a separate cohort.

Main Results:

  • Identified stable progression marker patterns, with 4 top-ranked markers consistently selected.
  • Local tracking of lung pattern transitions revealed a network of tissue transition pathways from healthy to diseased states.
  • The identified progression markers were predictive of patient outcomes, with comparable results in the external validation cohort.

Conclusions:

  • Unsupervised learning effectively identifies radiological disease progression markers in IPF.
  • These markers can predict patient outcomes.
  • The study elucidates pathways of radiological disease progression from healthy to diseased lung tissue.